Vir Biotechnology Inc
NASDAQ:VIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
Novan Inc
F:6LUA
|
US |
|
Tipiak SA
PAR:TIPI
|
FR |
|
Tufin Software Technologies Ltd
F:5TS
|
US |
|
Europcar Mobility Group SA
F:E7CD
|
FR |
|
F
|
Firma Oponiarska Debica SA
WSE:DBC
|
PL |
|
Chimeric Therapeutics Ltd
ASX:CHM
|
AU |
|
A
|
Averbuch Formica Center Ltd
TASE:AVER
|
IL |
|
N
|
Nike Inc
SGO:NKE
|
US |
|
S
|
Synopsys Inc
SWB:SYP
|
US |
|
Sterling Construction Company Inc
NASDAQ:STRL
|
US |
|
T
|
Triton Development SA
WSE:TRI
|
PL |
|
TOPPAN Holdings Inc
SWB:TPX
|
JP |
|
C
|
CWT International Ltd
HKEX:521
|
HK |
|
Monrif SpA
MIL:MON
|
IT |
|
GYP Properties Ltd
SGX:AWS
|
SG |
|
A
|
Aura Minerals Inc
TSX:ORA
|
US |
|
G
|
Grupo Clarin SA
BCBA:GCLA
|
AR |
|
First Reliance Bancshares Inc
OTC:FSRL
|
US |
|
Penguin International Ltd
SGX:BTM
|
SG |
|
A
|
Action SA
WSE:ACT
|
PL |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
US |
|
B
|
Bri-Chem Corp
TSX:BRY
|
CA |
|
Z
|
Zeder Investments Ltd
JSE:ZED
|
ZA |
Wall Street
Price Targets
VIR Price Targets Summary
Vir Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
VIR
is 20.74 USD
with a low forecast of 16.16 USD and a high forecast of 31.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VIR's stock price target?
Price Target
20.74
USD
According to Wall Street analysts, the average 1-year price target for
VIR
is 20.74 USD
with a low forecast of 16.16 USD and a high forecast of 31.5 USD.
What is Vir Biotechnology Inc's Revenue forecast?
Projected CAGR
13%
For the last 7 years the
compound annual growth rate for
Vir Biotechnology Inc's revenue is
30%.
The projected
CAGR
for the next 3 years is
13%.
